ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors.

Clinton Yam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.